Couldn't find what you looking for?


Scientists have discovered that taking a daily dose of Aspirin can prevent cancer and it reduces the chance that cancer will spread to other organs by around 50 percent. Find out more about the three new studies that support Aspirin as a cancer deterrent.
If you are among the millions of Americans who take an Aspirin each day to lower your risk for stroke or heart attack, you may also be lowering your risk for cancer. It’s true, according to a series of studies published in The Lancet and The Lancet Onocology Journal. What’s more, daily Aspirin is now thought to be beneficial as a treatment for those who already have cancer.

In the past it was found that daily Aspirin reduced the long-term risk of death because of cancer. Now, with these three new reports, experts are telling us that shorter-term effects are possible and Aspirin helps those already diagnosed with cancer. Peter Rothwell, an affiliate of Britain’s prestigious Oxford University reports that the likelihood that cancer will spread to other organs is reduced by forty to fifty percent with daily Aspirin usage.

Aspirin, a cheap over-the-counter medication, is typically used for pain and fever reduction. During the last fifty years doctors have been prescribing it to those who are at risk for heart attack and stroke. This drug works by reducing the risk of clot formation in the small blood vessels of the body. When the blood is thinner, it can pass through the vessels easier. Therefore doctors recommend Aspirin all the time. It is important to note that Aspirin increases the risk of stomach bleeding for some at-risk patients. This has started an intense debate about whether primary healthcare providers should advise people to take this drug daily on a regular basis. Some researchers have found that daily Aspirin use increased this risk of internal bleeding so, therefore, the risks outweigh the potential benefit.

Aspirin, also known as acetylsalicylic acid, was first isolated by Felix Hoffman. Hoffman was a German chemist who worded for the Bayer Corporation. The main undesirable side effects include gastrointestinal ulcers, tinnitus, and stomach bleeding. This is particularly true when it is taken in large doses.

Regardless of the controversy that surrounds this apparent miracle drug, studies support that Aspirin (even at a low dose) reduces the risk of developing some cancers, especially esophageal and bowel cancer. Rothwell and associates did point out that the effects do not show up until eight to ten years after Aspirin therapy has begun.
Peter Johnson, a chief physician of the Cancer Research Center in the U.K., reported that he and his associates are investigating the anti-cancer properties of Aspirin. Andrew Chan and Nancy Cook of Harvard Medical School support these findings as well.

In one of these studies, the researchers analyzed data from around fifty trials and found that taking a low-dose of daily Aspirin reduced the risk of death from cancer by around 40% after five years of daily use. More data disclosed that taking a daily Aspirin for three years reduced cancer risk by approximately 25% for both men and women alike. Another study by Rothwell and associates examined the impact of the Aspirin therapy on cancer metastasis. This time it was found that with six-and-a-half years of daily Aspirin use there is a 36% reduction in the risk of cancer with distant spread. Colorectal cancer patients had around a 75% reduction in risk when the Aspirin was taken daily. For people with solid cancer tumors, Aspirin use daily reduced cancer death by 35%.